| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |